Growth Metrics

Neogenomics (NEO) Non-Current Debt (2016 - 2020)

Historic Non-Current Debt for Neogenomics (NEO) over the last 8 years, with Q1 2020 value amounting to $90.6 million.

  • Neogenomics' Non-Current Debt rose 536.08% to $90.6 million in Q1 2020 from the same period last year, while for Mar 2020 it was $90.6 million, marking a year-over-year increase of 536.08%. This contributed to the annual value of $91.8 million for FY2019, which is 449.36% up from last year.
  • Latest data reveals that Neogenomics reported Non-Current Debt of $90.6 million as of Q1 2020, which was up 536.08% from $91.8 million recorded in Q4 2019.
  • Neogenomics' 5-year Non-Current Debt high stood at $94.2 million for Q2 2019, and its period low was $52.2 million during Q3 2016.
  • Moreover, its 5-year median value for Non-Current Debt was $70.1 million (2016), whereas its average is $75.8 million.
  • Per our database at Business Quant, Neogenomics' Non-Current Debt surged by 3424.62% in 2016 and then plummeted by 599.02% in 2018.
  • Neogenomics' Non-Current Debt (Quarter) stood at $70.1 million in 2016, then decreased by 5.04% to $66.6 million in 2017, then skyrocketed by 31.92% to $87.9 million in 2018, then increased by 4.49% to $91.8 million in 2019, then dropped by 1.33% to $90.6 million in 2020.
  • Its Non-Current Debt stands at $90.6 million for Q1 2020, versus $91.8 million for Q4 2019 and $93.0 million for Q3 2019.